Study of Eye Movement Testing and Therapy

This study has been completed.
Sponsor:
Information provided by:
Ohio State University
ClinicalTrials.gov Identifier:
NCT00472485
First received: May 9, 2007
Last updated: July 1, 2008
Last verified: July 2008
  Purpose

The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.


Condition Intervention
Saccadic Eye Movement Deficiency
Oculomotor Deficiency
Oculomotor Dysfunction
Procedure: eye movement therapy

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by Ohio State University:

Estimated Enrollment: 40
  Eligibility

Ages Eligible for Study:   8 Years to 13 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Children ages 8 to 13 with saccadic eye movement deficit

Exclusion Criteria:

  • Previous saccadic eye movement therapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472485

Locations
United States, Ohio
The Ohio State University
Columbus, Ohio, United States, 43210
Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00472485     History of Changes
Other Study ID Numbers: 00H0185
Study First Received: May 9, 2007
Last Updated: July 1, 2008
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on September 16, 2014